|
|
US 7,547,731 B2 |
|
| Formamide derivatives for the treatment of diseases |
| Alan Daniel Brown, Sandwich (United Kingdom); Mark Edward Bunnage, Sandwich (United Kingdom); Charlotte Alice Louise Lane, Sandwich (United Kingdom); Russell Andrew Lewthwaite, Sandwich (United Kingdom); Paul Alan Glossop, Sandwich (United Kingdom); Kim James, Sandwich (United Kingdom); and David Anthony Price, Sandwich (United Kingdom) |
| Assigned to Pfizer Inc, New York, N.Y. (US) |
| Filed on Jul. 03, 2007, as Appl. No. 11/773,012. |
| Application 11/773012 is a continuation of application No. 11/086035, filed on Mar. 21, 2005, granted, now 7,241,810. |
| Claims priority of provisional application 60/591777, filed on Jul. 27, 2004. |
| Claims priority of provisional application 60/642275, filed on Jan. 07, 2005. |
| Claims priority of application No. 04290767 (EP), filed on Mar. 23, 2004; application No. 0425054.4 (GB), filed on Nov. 12, 2004; and application No. 05708714 (EP), filed on Mar. 10, 2005. |
| Prior Publication US 2008/0207689 A1, Aug. 28, 2008 |
| This patent is subject to a terminal disclaimer. |
| Int. Cl. A61K 31/167 (2006.01); C07C 233/24 (2006.01)
|